Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Claes Wahlestedt
Affiliation
ORCID
Career Start Year
1982
Papers
308
H Index
89
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37509143
Dopamine Transporter Knockout Rats Display Epigenetic Alterations in Response to Cocaine Exposure.
2023
37759724
Low-Dose Chidamide Treatment Displays Sex-Specific Differences in the 3xTg-AD Mouse.
2023
37662844
Nucleic acid-based therapeutics for the treatment of central nervous system disorders.
2023
37288167
Transcriptomics for Clinical and Experimental Biology Research: Hang on a Seq.
Adv Genet (Hoboken)
2023
37466388
Long non-coding RNA-targeting therapeutics: discovery and development update.
2023
36765087
Author Correction: Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis.
Nat Commun
2023
37253858
Amplifying gene expression with RNA-targeted therapeutics.
2023
37171575
Investigating the Synergistic Potential of Low-Dose HDAC3 Inhibition and Radiotherapy in Alzheimer's Disease Models.
2023
34757001
JQ1 attenuates psychostimulant- but not opioid-induced conditioned place preference.
Behavioural Brain Research
2022
36250017
Natural antisense transcripts as drug targets.
Frontiers in Molecular Biosciences
2022
36077629
Functional Drug Screening of Small Molecule Inhibitors of Epigenetic Modifiers in Refractory AML Patients.
Cancers (Basel)
2022
35789594
Safety and pharmacokinetics of a highly bioavailable resveratrol preparation (JOTROL ).
2022
35723129
Erratum to: JOTROL, a Novel Formulation of Resveratrol, Shows Beneficial Effects in the 3xTg-AD Mouse Model.
Journal of Alzheimer's Disease
2022
34735897
A novel strategy for combination of clofarabine and pictilisib is synergistic in gastric cancer.
Transl Oncol
2022
35037854
A human-based multi-gene signature enables quantitative drug repurposing for metabolic disease.
Elife
2022
35135840
DOT1L Is a Novel Cancer Stem Cell Target for Triple-Negative Breast Cancer.
Clinical Cancer Research
2022
31373129
Dysregulation of the histone demethylase KDM6B in alcohol dependence is associated with epigenetic regulation of inflammatory signaling pathways.
Addict Biol
2021
33996898
Nucleic Acid-Based Therapeutics in Orphan Neurological Disorders: Recent Developments.
Frontiers in Molecular Biosciences
2021
33459720
Sexual Dimorphism in the 3xTg-AD Mouse Model and Its Impact on Pre-Clinical Research.
Journal of Alzheimer's Disease
2021
32656646
Direct Administration and Gene Modulation Using Antisense Oligonucleotides Within the CNS.
Cellular and Molecular Neurobiology
2021
33077485
Dual Screen for Efficacy and Toxicity Identifies HDAC Inhibitor with Distinctive Activity Spectrum for BAP1-Mutant Uveal Melanoma.
Molecular Cancer Research
2021
33414398
Alcohol use disorder causes global changes in splicing in the human brain.
Transl Psychiatry
2021
34827542
Epigenetic Small Molecules Rescue Nucleocytoplasmic Transport and DNA Damage Phenotypes in C9ORF72 ALS/FTD.
Brain Sciences
2021
34377851
A novel knockout mouse model of the noncoding antisense () gene displays increased endogenous Bdnf protein and improved memory function following exercise.
Heliyon
2021
32831302
A Neurite Outgrowth Assay and Neurotoxicity Assessment with Human Neural Progenitor Cell-Derived Neurons.
Journal of Visualized Experiments
2020
32093728
Dipeptide repeat proteins inhibit homology-directed DNA double strand break repair in C9ORF72 ALS/FTD.
Molecular Neurodegeneration
2020
33584810
Emerging Technologies for Genome-Wide Profiling of DNA Breakage.
Frontiers in Genetics
2020
32882003
Antitumor activity of the dual BET and CBP/EP300 inhibitor NEO2734.
Blood advances
2020
32755574
Molecular Transducers of Human Skeletal Muscle Remodeling under Different Loading States.
Cell Reports
2020
33080337
Molecular mechanisms of psychiatric diseases.
Neurobiology of Disease
2020
32913560
The bromodomain inhibitor IBET-151 attenuates vismodegib-resistant esophageal adenocarcinoma growth through reduction of GLI signaling.
Oncotarget
2020
31311938
Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis.
Nat Commun
2019
31559706
The novel BET-CBP/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild-type prostate cancer.
EMBO Mol Med
2019
31862872
Novel approach reveals genomic landscapes of single-strand DNA breaks with nucleotide resolution in human cells.
Nature Communications
2019
30504275
Enhancement of BDNF Expression and Memory by HDAC Inhibition Requires BET Bromodomain Reader Proteins.
J Neurosci
2019
30975544
Vitamin C supplementation expands the therapeutic window of BETi for triple negative breast cancer.
EBioMedicine
2019
31168962
Longevity-related molecular pathways are subject to midlife "switch" in humans.
Aging Cell
2019
31366484
Ovarian Cancer Treatment Stratification Using Drug Sensitivity Testing.
Anticancer Research
2019
30841499
HDAC Inhibitors Induce Expression and Promote Neurite Outgrowth in Human Neural Progenitor Cells-Derived Neurons.
International Journal of Molecular Sciences
2019
28040748
How the strengths of Lisp-family languages facilitate building complex and flexible bioinformatics applications.
Brief Bioinform
2018
30552330
Drug and disease signature integration identifies synergistic combinations in glioblastoma.
Nat Commun
2018
30397132
Inhibition of HDAC3 reverses Alzheimer's disease-related pathologies in vitro and in the 3xTg-AD mouse model.
Proceedings of the National Academy of Sciences of the United States of America
2018
30212533
Ex vivo drug sensitivity testing as a means for drug repurposing in esophageal adenocarcinoma.
PLoS ONE
2018
30017313
Strategies to Annotate and Characterize Long Noncoding RNAs: Advantages and Pitfalls.
Trends in Genetics
2018
30099093
EZH1 is an antipsychotic-sensitive epigenetic modulator of social and motivational behavior that is dysregulated in schizophrenia.
Neurobiol Dis
2018
30582583
Purification of H3 and H4 Histone Proteins and the Quantification of Acetylated Histone Marks in Cells and Brain Tissue.
Journal of Visualized Experiments
2018
30078338
Developments in lncRNA drug discovery: where are we heading?
Expert Opinion on Drug Discovery
2018
29986096
A coding and non-coding transcriptomic perspective on the genomics of human metabolic disease.
Nucleic Acids Res
2018
29180474
Vitamin C Sensitizes Melanoma to BET Inhibitors.
Cancer Res
2018
29483230
Cocaine Exposure Increases Blood Pressure and Aortic Stiffness via the miR-30c-5p-Malic Enzyme 1-Reactive Oxygen Species Pathway.
Hypertension
2018
1 - 50 of 308
Column Actions
Search
Recommended Authors
Collaborators
Eugene R Zabarovsky
Co-authored papers
13
Salim Mottagui-Tabar
Co-authored papers
13
Boris Lenhard
MRC London Institute of Medical Sciences
Co-authored papers
11
Yoshihide Hayashizaki
Center for Integrative Medical Sciences
Co-authored papers
10
Piero Carninci
RIKEN Center for Integrative Medical Sciences
Co-authored papers
9
Alexei Protopopov
The University of MD Anderson Cancer Center
Co-authored papers
9
Philipp Kapranov
Co-authored papers
8
Pär G Engström
Co-authored papers
8
Jun Kawai
RIKEN Center for Integrative Medical Sciences
Co-authored papers
7
Nagi G Ayad
Co-authored papers
7
Alistair R R Forrest
RIKEN Center for Integrative Medical Sciences
Co-authored papers
6
Wyeth W Wasserman
BC Children's Hospital Research Institute, University of British Columbia
Co-authored papers
6
Christine A Wells
The University of Melbourne
Co-authored papers
6
Harukazu Suzuki
RIKEN Center for Integrative Medical Sciences
Co-authored papers
6
Alistair M Chalk
Co-authored papers
6
Hideya Kawaji
RIKEN Center for Integrative Medical Sciences
Co-authored papers
6
Vladimir B Bajic
King Abdullah University of Science and Technology (KAUST)
Co-authored papers
5
Timothy Ravasi
Okinawa Institute of Science and Technology Graduate University
Co-authored papers
5
Chikatoshi Kai
Co-authored papers
5
David A Hume
Mater Research Institute-UQ, Translational Research Institute
Co-authored papers
5
Albin Sandelin
University of Copenhagen
Co-authored papers
5
John S Mattick
Australia UNSW RNA Institute
Co-authored papers
5
Martin S Taylor
Institute of Genetics and Cancer, University of Edinburgh
Co-authored papers
4
Martin C Frith
Artificial Intelligence Research Center, University of Tokyo
Co-authored papers
4
Yasuhiro Tomaru
Co-authored papers
4
William E Kraus
Duke Molecular Physiology Institute, Duke University School of Medicine
Co-authored papers
4
Takeya Kasukawa
RIKEN Center for Integrative Medical Sciences
Co-authored papers
4
Sean M Grimmond
The University of Melbourne
Co-authored papers
4
Paul J Kenny
Co-authored papers
4
Colin A Semple
Institute of Genetics and Cancer, University of Edinburgh
Co-authored papers
4
1 - 30